Congress:
EuroSafe Imaging 2017
Keywords:
Quality assurance, Education and training, Radiation safety, Dosimetry, Fluoroscopy, Digital radiography, CT, Radiation physics, Action 8 - Radiation protection training and learning material, Action 2 - Clinical diagnostic reference levels (DRLs), Action 6 - Education and training in medical radiation protection, Action 3 - Optimisation, diagnostic reference levels, image quality
Authors:
E. Vano, D. L. Miller, M. M. Rehani
DOI:
10.1594/esi2017/ESI-0024
Background/Introduction
Committee 3 (Protection in Medicine) of the International Commission on Radiological Protection (ICRP) develops recommendations and guidance for protection of patients,
staff,
and the public against radiation exposure when ionising radiation is used for medical diagnosis,
therapy,
or biomedical research (ICRP,
2007).
Recently,
the Main Commission of the ICRP decided to also include Veterinary Medicine as part of the C3 mandate.
During the 2013–2017 term,
Committee 3 is composed of 16 members with expertise in different areas of radiological protection in medicine: medical physics; nuclear medicine; radiology (including several subspecialties within radiology); and radiation oncology.
They are: Eliseo Vano (Chair); Donald Miller (Vice Chair); Madan Rehani (Secretary); Katrine Ahlstrom-Riklund; Kimberly Applegate; Michel Bourguignon; Lawrence Dauer; Sandor Demeter; Keon Kang; Pek-Lan Khong; Reinhard Loose; Pedro Ortiz Lopez; Colin Martin; Pierre Scalliet; Yoshiharu Yonekura; and Baorong Yue.
Fig.
1 shows the Members of C3 and a representative (O.
Holmberg) of the IAEA.
The membership of Committee 3 demonstrates a wide geographical distribution.
Members are from 12 different countries.
C3 currently has two emeritus members,
Sören Mattsson and Marvin Rosenstein,
who contribute actively to the ongoing reports.
A public summary of the annual meetings is available on the ICRP website (http://www.icrp.org/icrp_group.asp?id=9).
ICRP maintains formal relations with other organisations with an interest in radiological protection through specific agreements,
or by granting special liaison status to organisations whose work is relevant to the ICRP mandate.
Representatives from the World Health Organization (WHO) and from the International Atomic Energy Agency (IAEA) attend the annual meetings of Committee 3.
International organisations and stakeholders are encouraged to propose topics of interest for new reports.
In addition,
a new mechanism,
introduced at the second ICRP symposium,
provides opportunities for symposium participants to provide input on suggested topics to the Commission’s Committees.
The members of each Committee review the proposals relevant to their Committee’s area of responsibility,
and evaluate the need to produce reports on specific topics.
Each Committee forwards its recommendations to the Main Commission.
The work suggested by the Committees is subject to approval by the Main Commission.